We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sekisui XenoTech Appoints New COO

News   Oct 20, 2017

 
Sekisui XenoTech Appoints New COO
 
 
 

RELATED ARTICLES

Insufficient Evidence To Support Herbal Medicines for Weight Loss

News

Researchers from the University of Sydney have conducted the first global review of herbal medicines for weight loss in 19 years, finding insufficient evidence to recommend any current treatments.

READ MORE

Social Media’s Power in Spreading Vaccine Misinformation

News

People who rely on social media for information were more likely to be misinformed about vaccines than those who rely on traditional media, according to a study of vaccine knowledge and media use.

READ MORE

Novel Drug Targets Advanced Kidney Cancer

News

Scientists have reported promising activity of a novel drug called MK-6482, that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease. The study authors concluded that the drug was well-tolerated with a favorable safety profile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE